Sarah Whelan, PhD
Science Writer
at Technology Networks
Sarah joined Technology Networks in 2022 after completing a PhD in cancer biology, where her research focused on the development of colon cancers. In her role as science writer and editor, Sarah covers scientific news and a range of other content types, leading the site's coverage of drug discovery, biopharma and cancer research content.
Education
Areas of Expertise
Got a Question for Sarah Whelan, PhD?
Get in touch using the contact form linked here and we’ll get back to you shortly
Published Content
Total: 290
News
Diabetes Drug Shows Promise for Parkinson’s Disease in Trial
Results from a Phase 2 clinical trial suggest that lixisenatide – a drug used to treat type 2 diabetes – may also slow the progression of Parkinson’s disease symptoms.
News
Ancient DNA May Uncover Ethnic Differences in Childhood Cancer
Researchers have harnessed ancient DNA to trace a genetic variant – one that increases the risk of a type of childhood cancer – back to the first people who migrated into the Americas approximately 13,000 years ago.
Infographic
The Genetic Basis of Cancer
Cancer is inherently a genetic disease, and advances in our knowledge of the genetic basis of cancer can help to guide earlier diagnosis and improve treatments to benefit patients.
Infographic
The Basics of Bioprocessing
Download this infographic to learn more about what bioprocessing is, the techniques and systems used in bioprocessing, and key considerations, challenges and future trends for the field.
News
No Evidence That CBD Products Reduce Chronic Pain, Study Finds
A new study has concluded that there is no evidence that cannabidiol (CBD) products reduce chronic pain, suggesting that they are not value for money and even have the potential to harm health.
Industry Insight
Setting the Stage for Multipurpose Drugs
We spoke with Dr. Bryan Oronsky, chief development officer at EpicentRx, to discover more about the promise of multipurpose drugs and the potential of EpicentRx’s nibrozetone (RRx-001) for several conditions.
News
Gene Editing Can Eliminate HIV From Cell Culture, Researchers Claim
The genome editing tool CRISPR-Cas9 can eliminate HIV viruses from lab-cultured cells, according to not-yet peer-reviewed research to be presented at this year’s European Congress of Clinical Microbiology and Infectious Diseases (ECCMID).
Listicle
Genetics in Disease
Some genetic diseases, like sickle cell anemia, are hereditary and present at birth. Others can be caused by spontaneous mutations, either arising from errors in DNA replication or exposure to environmental factors.
News
Metformin Tied to Production of “Anti-Hunger” Molecule
The same “anti-hunger” molecule stimulated by vigorous exercise can also be produced by the common diabetes drug metformin, according to a new study from Stanford University.
News
Could Genetics Influence Cancer Risk From Red and Processed Meats?
Researchers have explored whether genetics can influence the risk of colorectal cancer from the consumption of red and processed meat, identifying two genetic markers that may put some people at increased risk.
Advertisement
